This buffering occurs within 6 to 12 hours after the onset of hypocapnia, with substantial restoration of CBF towards baseline observed as early as 30 minutes after onset of hypocapnia in both healthy volunteers and brain-injured patients [ 9, 10].
Significant reductions from baseline were observed as early as 4 weeks from the start of therapy.
However, vascular changes which were observed as early as 4 8 h regressed to baseline 24 h after treatment 53.
Healthcare costs and fracture-free survivals observed at baseline, as well as those expected for each given scenario, were computed as follows.
Third, healthcare annual costs observed at baseline, as well as that expected for a given scenario, were estimated.
Second, health outcomes were estimated by means of the years spent free from fracture observed at baseline, as well as those expected for a given scenario.
Comparing side effects of obese vs non-obese patients no difference in frequency or strength could be observed at baseline as well as after 3 months of AI treatment (Table 2).
We controlled for the presence of these and other comorbidities observed at baseline as well as a large number of other demographic and clinical characteristics, but doing so had very little effect on the cost estimates and no effect on the relative cost differences between patients who did and did not progress.
Regarding FSH, an inverse correlation between BMI and FSH serum levels could be observed at baseline (r=−0.55, P<0.01) as well as after 3 months of endocrine treatment with an AI (r=−0.34, P=0.06).
A very strong correlation between FSH serum levels measured by the clinical routine laboratory and FSH serum levels measured by the dedicated central laboratory could be observed at baseline (r=0.988, P<0.01) as well as after 3 months of treatment with an AI (r=0.964, P<0.01).
